(Q95818623)

English

Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial

scientific article published on 22 May 2020

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32450106%20AND%20SRC:MED&resulttype=core&format=json

30 May 2020

Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32450106%20AND%20SRC:MED&resulttype=core&format=json

30 May 2020

1 reference

based on heuristic

inferred from title

COVID-19 vaccine

1 reference

based on heuristic

inferred from title

author name string

Feng-Cai Zhu

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32450106%20AND%20SRC:MED&resulttype=core&format=json

30 May 2020

Yu-Hua Li

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32450106%20AND%20SRC:MED&resulttype=core&format=json

30 May 2020

Xu-Hua Guan

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32450106%20AND%20SRC:MED&resulttype=core&format=json

30 May 2020

Li-Hua Hou

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32450106%20AND%20SRC:MED&resulttype=core&format=json

30 May 2020

Wen-Juan Wang

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32450106%20AND%20SRC:MED&resulttype=core&format=json

30 May 2020

Jing-Xin Li

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32450106%20AND%20SRC:MED&resulttype=core&format=json

30 May 2020

Shi-Po Wu

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32450106%20AND%20SRC:MED&resulttype=core&format=json

30 May 2020

Bu-Sen Wang

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32450106%20AND%20SRC:MED&resulttype=core&format=json

30 May 2020

Zhao Wang

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32450106%20AND%20SRC:MED&resulttype=core&format=json

30 May 2020

Lei Wang

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32450106%20AND%20SRC:MED&resulttype=core&format=json

30 May 2020

Si-Yue Jia

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32450106%20AND%20SRC:MED&resulttype=core&format=json

30 May 2020

Hu-Dachuan Jiang

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32450106%20AND%20SRC:MED&resulttype=core&format=json

30 May 2020

Ling Wang

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32450106%20AND%20SRC:MED&resulttype=core&format=json

30 May 2020

Tao Jiang

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32450106%20AND%20SRC:MED&resulttype=core&format=json

30 May 2020

Yi Hu

15

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32450106%20AND%20SRC:MED&resulttype=core&format=json

30 May 2020

Jin-Bo Gou

16

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32450106%20AND%20SRC:MED&resulttype=core&format=json

30 May 2020

Sha-Bei Xu

17

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32450106%20AND%20SRC:MED&resulttype=core&format=json

30 May 2020

Jun-Jie Xu

18

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32450106%20AND%20SRC:MED&resulttype=core&format=json

30 May 2020

Xue-Wen Wang

19

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32450106%20AND%20SRC:MED&resulttype=core&format=json

30 May 2020

Wei Wang

20

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32450106%20AND%20SRC:MED&resulttype=core&format=json

30 May 2020

Wei Chen

21

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32450106%20AND%20SRC:MED&resulttype=core&format=json

30 May 2020

publication date

22 May 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32450106%20AND%20SRC:MED&resulttype=core&format=json

30 May 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32450106%20AND%20SRC:MED&resulttype=core&format=json

30 May 2020

A Novel Coronavirus from Patients with Pneumonia in China, 2019

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2820%2931208-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2820%2931208-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Compassionate Use of Remdesivir for Patients with Severe Covid-19

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2820%2931208-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical course and mortality risk of severe COVID-19

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2820%2931208-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact assessment of non-pharmaceutical interventions against coronavirus disease 2019 and influenza in Hong Kong: an observational study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2820%2931208-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Spread of SARS-CoV-2 in the Icelandic Population

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2820%2931208-3

7 January 2021

based on heuristic

inferred from DOI database lookup

SARS-CoV-2 Vaccines: Status Report

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2820%2931208-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2820%2931208-3

7 January 2021

based on heuristic

inferred from DOI database lookup

A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2820%2931208-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and immunogenicity of a chimpanzee adenovirus-vectored Ebola vaccine in healthy adults: a randomised, double-blind, placebo-controlled, dose-finding, phase 1/2a study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2820%2931208-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Quantifying Adenovirus-Neutralizing Antibodies by Luciferase Transgene Detection: Addressing Preexisting Immunity to Vaccine and Gene Therapy Vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2820%2931208-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and immunogenicity of a novel recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in China: preliminary report of a randomised, double-blind, placebo-controlled, phase 1 trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2820%2931208-3

7 January 2021

based on heuristic

inferred from DOI database lookup

T cell responses are required for protection from clinical disease and for virus clearance in severe acute respiratory syndrome coronavirus-infected mice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2820%2931208-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Virus-specific memory CD8 T cells provide substantial protection from lethal severe acute respiratory syndrome coronavirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2820%2931208-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2820%2931208-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical characteristics of severe acute respiratory syndrome coronavirus 2 reactivation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2820%2931208-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Developing Covid-19 Vaccines at Pandemic Speed

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2820%2931208-3

7 January 2021

based on heuristic

inferred from DOI database lookup

COVID-19: immunopathology and its implications for therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2820%2931208-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and immunogenicity of a heterologous prime-boost Ebola virus vaccine regimen - ChAd3-EBO-Z followed by MVA-EBO-Z in healthy adults in the UK and Senegal

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2820%2931208-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and immunogenicity of GamEvac-Combi, a heterologous VSV- and Ad5-vectored Ebola vaccine: An open phase I/II trial in healthy adults in Russia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2820%2931208-3

7 January 2021

based on heuristic

inferred from DOI database lookup

A two-dose heterologous prime-boost vaccine regimen eliciting sustained immune responses to Ebola Zaire could support a preventive strategy for future outbreaks

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2820%2931208-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2820%2931208-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Recent Advances in the Vaccine Development Against Middle East Respiratory Syndrome-Coronavirus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2820%2931208-3

7 January 2021

based on heuristic

inferred from DOI database lookup

A human SARS-CoV neutralizing antibody against epitope on S2 protein

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2820%2931208-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunodominant SARS Coronavirus Epitopes in Humans Elicited both Enhancing and Neutralizing Effects on Infection in Non-human Primates

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2820%2931208-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Recombinant adenovirus type 5 HIV gag/pol/nef vaccine in South Africa: unblinded, long-term follow-up of the phase 2b HVTN 503/Phambili study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2820%2931208-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q95818623&oldid=1760435850"